$STME
Stimcell Energetics Inc.

2023 Q2 Form 10-K Financial Statement

#000139390523000167 Filed on April 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2 2022
Revenue $70.00 $2.780K $6.070K
YoY Change -97.48% -58.88% -10.21%
Cost Of Revenue $550.00 $540.00 $2.032K
YoY Change 1.85% -83.33% -37.28%
Gross Profit -$480.00 $2.240K $4.033K
YoY Change -121.43% -36.36% 14.57%
Gross Profit Margin -685.71% 80.58% 66.44%
Selling, General & Admin $63.88K $103.6K $523.9K
YoY Change -38.35% -77.18% 15.37%
% of Gross Profit 4625.45% 12989.59%
Research & Development $420.00 $52.53K $150.7K
YoY Change -99.2% -77.12% -34.35%
% of Gross Profit 2345.09% 3736.9%
Depreciation & Amortization $0.00 $210.00 $1.150K
YoY Change -100.0% -61.11% -52.67%
% of Gross Profit 9.38% 28.51%
Operating Expenses $64.30K $156.3K $675.7K
YoY Change -58.87% -77.21% -1.51%
Operating Profit -$64.78K -$154.1K -$671.7K
YoY Change -57.96% -77.42% -1.6%
Interest Expense -$14.61K -$8.460K $25.69K
YoY Change 72.7% -73.58% -180.22%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$79.38K -$162.6K -$697.4K
YoY Change -51.17% -82.15% -23.44%
Income Tax
% Of Pretax Income
Net Earnings -$79.38K -$162.6K -$697.4K
YoY Change -51.17% -82.15% -23.44%
Net Earnings / Revenue -113400.0% -5847.48% -11488.95%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 62.92M shares 62.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.30K $24.38K $24.38K
YoY Change 303.2% 17.49% 17.49%
Cash & Equivalents $98.30K $24.38K
Short-Term Investments
Other Short-Term Assets $4.975K $16.96K $16.97K
YoY Change -70.67% -43.99% -43.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $103.3K $41.34K $41.34K
YoY Change 149.78% -19.01% -19.02%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $103.3K $41.34K $41.34K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $103.3K $41.34K $41.34K
YoY Change 149.78% -20.86% -20.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $408.3K $442.4K $442.4K
YoY Change -7.72% 2.51% 2.51%
Accrued Expenses $36.56K $28.88K $28.88K
YoY Change 26.61% -17.92% -17.91%
Deferred Revenue
YoY Change
Short-Term Debt $1.041M $657.6K $657.6K
YoY Change 58.26% 91.35% 91.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.489M $2.050M $2.050M
YoY Change 21.38% 25.92% 25.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.489M $2.050M $2.050M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.489M $2.050M $2.050M
YoY Change 21.38% 25.92% 25.92%
SHAREHOLDERS EQUITY
Retained Earnings -$10.15M -$9.658M
YoY Change 5.13% 7.78%
Common Stock $62.92K $62.92K
YoY Change 0.0% 1.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.385M -$2.009M -$2.009M
YoY Change
Total Liabilities & Shareholders Equity $103.3K $41.34K $41.34K
YoY Change 149.78% -20.86% -20.87%

Cashflow Statement

Concept 2023 Q2 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$79.38K -$162.6K -$697.4K
YoY Change -51.17% -82.15% -23.44%
Depreciation, Depletion And Amortization $0.00 $210.00 $1.150K
YoY Change -100.0% -61.11% -52.67%
Cash From Operating Activities -$25.62K -$94.58K -$450.6K
YoY Change -72.91% -36.06% -19.6%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 116.4K 88.09K $454.0K
YoY Change 32.1% -37.93% -15.16%
NET CHANGE
Cash From Operating Activities -25.62K -94.58K -$450.6K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 116.4K 88.09K $454.0K
Net Change In Cash 90.75K -6.490K $3.627K
YoY Change -1498.31% 7.99% -113.48%
FREE CASH FLOW
Cash From Operating Activities -$25.62K -$94.58K -$450.6K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$94.58K -$450.6K
YoY Change -36.06% -19.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-54500
CY2022 dei Entity Registrant Name
EntityRegistrantName
Cell MedX Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3939625
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
123 W. Nye Ln, Suite 446
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Carson City
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89706
CY2022 dei City Area Code
CityAreaCode
844
CY2022 dei Local Phone Number
LocalPhoneNumber
238-2692
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
5774106 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62923063 shares
CY2022 dei Auditor Name
AuditorName
DALE MATHESON CARR-HILTON LABONTE LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2022 dei Auditor Firm
AuditorFirmId
1173
CY2022Q2 us-gaap Cash
Cash
24380 usd
CY2021Q2 us-gaap Cash
Cash
20753 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
16964 usd
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
30294 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
41344 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
51047 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1195 usd
CY2022Q2 us-gaap Assets
Assets
41344 usd
CY2021Q2 us-gaap Assets
Assets
52242 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
442439 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
431593 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28877 usd
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35183 usd
CY2022Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
921451 usd
CY2021Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
817856 usd
CY2022Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
546720 usd
CY2021Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
237837 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
110888 usd
CY2021Q2 us-gaap Notes Payable
NotesPayable
105831 usd
CY2022Q2 us-gaap Liabilities
Liabilities
2050375 usd
CY2021Q2 us-gaap Liabilities
Liabilities
1628300 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62923063 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62073064 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
62923 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
62073 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7272701 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7076476 usd
CY2022Q2 fil Reserves
Reserves
366493 usd
CY2021Q2 fil Reserves
Reserves
366493 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9657735 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8960356 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53413 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-120744 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2009031 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1576058 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41344 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52242 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2032 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3240 usd
CY2022 us-gaap Gross Profit
GrossProfit
4033 usd
CY2021 us-gaap Gross Profit
GrossProfit
3522 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1145 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2434 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
189649 usd
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
268056 usd
CY2022 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
0 usd
CY2021 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
261 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
334223 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
185777 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
42568 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
150709 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
229581 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
675726 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
728677 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
153661 usd
CY2022 us-gaap Interest Expense
InterestExpense
25686 usd
CY2021 us-gaap Interest Expense
InterestExpense
32020 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-697379 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-910836 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
67331 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-159358 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-630048 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1070194 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62798817 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58763796 shares
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1520344 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
207000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
124243 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
683237 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-910836 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-159358 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1576058 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
60000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
37075 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-697379 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
67331 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2009031 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-697379 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-910836 usd
CY2022 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
25686 usd
CY2021 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
32020 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1145 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2434 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
42568 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-153661 usd
CY2022 fil Non Cash Ir Fees
NonCashIrFees
37075 usd
CY2021 fil Non Cash Ir Fees
NonCashIrFees
18333 usd
CY2022 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-44906 usd
CY2021 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
119005 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12714 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-12210 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-15397 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19953 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54080 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6302 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
25 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
112115 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
138177 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-450591 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-560432 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1574 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1574 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
293971 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
328096 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
160000 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
207000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
453971 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
535096 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
247 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
2573 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3627 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24337 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20753 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45090 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24380 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20753 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
124243 usd
CY2022Q2 us-gaap Loans Payable
LoansPayable
520484 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9657735 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Accounting estimates</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, fair value of financial instruments and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
26236 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5038000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18682605 shares
CY2022Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
546720 usd
CY2021Q2 us-gaap Loans Payable
LoansPayable
230668 usd
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
7169 usd
CY2022Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
921451 usd
CY2021Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
817856 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
193006 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
245137 usd
CY2021Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
237837 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1195 usd
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1836 usd
CY2021 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
1574 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1145 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2434 usd
CY2022 fil Foreign Exchange Equipment Gl
ForeignExchangeEquipmentGL
-50 usd
CY2021 fil Foreign Exchange Equipment Gl
ForeignExchangeEquipmentGL
219 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1195 usd
CY2022 us-gaap Gross Profit
GrossProfit
4033 usd
CY2021 us-gaap Gross Profit
GrossProfit
3522 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
110888 usd
CY2021Q2 us-gaap Notes Payable
NotesPayable
105831 usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
400000 shares
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
300000 shares
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
60000 usd
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
149999 shares
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
37075 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2484500 shares
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
153661 usd
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2550000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7050000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.05
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.35
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.35
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2050000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2550000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2050000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.35
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16132605 shares
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18864605 shares
CY2022 fil Warrants Issued
WarrantsIssued
0 shares
CY2021 fil Warrants Issued
WarrantsIssued
988000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
300000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
12844605 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
3720000 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2988000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16132605 shares
CY2021Q2 fil Net Operating Losses Which May Be Carried Forward Foreign
NetOperatingLossesWhichMayBeCarriedForwardForeign
1328000 usd
CY2022Q2 fil Number Of Warrants Exercisable
NumberOfWarrantsExercisable
2988000 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-697379 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-910836 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-146450 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-191276 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-28000 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-15550 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-21724 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
90000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-192000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
100000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
404000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1321000 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1250000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
456000 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
359000 usd
CY2022Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
5000 usd
CY2021Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
73000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1782000 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1682000 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6291000 usd
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5953000 usd
CY2022Q2 fil Net Operating Losses Which May Be Carried Forward Foreign
NetOperatingLossesWhichMayBeCarriedForwardForeign
1689000 usd

Files In Submission

Name View Source Status
0001393905-23-000167-index-headers.html Edgar Link pending
0001393905-23-000167-index.html Edgar Link pending
0001393905-23-000167.txt Edgar Link pending
0001393905-23-000167-xbrl.zip Edgar Link pending
cmxc-20220531.htm Edgar Link pending
cmxc-20220531.xsd Edgar Link pending
cmxc10k_1.jpg Edgar Link pending
cmxc10k_2.jpg Edgar Link pending
cmxc_ex1050.htm Edgar Link pending
cmxc_ex1051.htm Edgar Link pending
cmxc_ex1052.htm Edgar Link pending
cmxc_ex1053.htm Edgar Link pending
cmxc_ex1059.htm Edgar Link pending
cmxc_ex1060.htm Edgar Link pending
cmxc_ex1061.htm Edgar Link pending
cmxc-20220531_cal.xml Edgar Link unprocessable
cmxc-20220531_pre.xml Edgar Link unprocessable
cmxc-20220531_def.xml Edgar Link unprocessable
cmxc-20220531_lab.xml Edgar Link unprocessable
cmxc-20220531_htm.xml Edgar Link completed
cmxc_ex1062.htm Edgar Link pending
cmxc_ex1063.htm Edgar Link pending
cmxc_ex1064.htm Edgar Link pending
cmxc_ex1065.htm Edgar Link pending
cmxc_ex1066.htm Edgar Link pending
cmxc_ex211.htm Edgar Link pending
cmxc_ex311.htm Edgar Link pending
cmxc_ex312.htm Edgar Link pending
cmxc_ex321.htm Edgar Link pending
cmxc_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable